Glycomine is a biotechnology company developing therapies for rare diseases, specifically targeting PMM2-CDG with its investigational drug GLM101.

Relief Cardiovascular develops a transcatheter smart implant for managing heart failure, specifically targeting diuretic-resistant cases.